Table 1 General overview: Patients with malignant primary disease in two hospices
From: Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis
Category and related p-valuea | Hospice 1 (H1) | Hospice 2 (H2) | Total | |||
|---|---|---|---|---|---|---|
Total number of patients | 336 | 100% | 370 | 100% | 706 | 100% |
Patients with malignant disease | 312 | 93% | 333 | 90% | 645 | 91% |
Evaluation: Patients with a malignant disease | ||||||
Age in years (median, p = 0.98) | 72 (range: 33–96) | 72 (range: 42–101) | 72 (range: 33–101) | |||
Residence time in days (p = 0.66) | 30 (range: 0–440) | 26 (range: 0–335) | 28 (range: 0–440) | |||
Gender (p = 0.18) | ||||||
Male | 141 | 45% | 132 | 40% | 273 | 42% |
Female | 171 | 55% | 201 | 60% | 372 | 58% |
Malignant disease (primary diagnosis) | ||||||
Bronchial carcinomas (p = 0.92) | 56 | 18% | 61 | 18% | 117 | 18% |
Gastrointestinal cancers (p = 0.67) | 97 | 31% | 98 | 29% | 195 | 30% |
Gynecological cancers (p = 0.03) | 47 | 15% | 73 | 22% | 120 | 19% |
Brain cancers (p = 0.49) | 25 | 8% | 32 | 10% | 57 | 9% |
ENT tract cancers (p = 0.57) | 12 | 4% | 16 | 5% | 28 | 4% |
Other cancer (bone cancers, thyroid carcinomas, skin malignomas, cancer of unknown pirmary; p = 0.72) | 14 | 5% | 18 | 5% | 32 | 5% |
Urological cancers (p = 0.78) | 30 | 10% | 29 | 9% | 59 | 9% |
Haematological systemic diseases (p < 0.01) | 31 | 10% | 6 | 2% | 37 | 6% |
Clinical course | ||||||
Discharge (p = 1.00) | 13 | 4% | 13 | 4% | 26 | 4% |
Hospitalization (p = 0.69) | 2 | 1% | 4 | 1% | 6 | 1% |
For survival time see Fig. 1 | ||||||